Suscribirse

Altered CDHR3 Expression in asthmatic children bronchial epithelium - 09/05/26

Doi : 10.1016/j.rmr.2025.12.026 
E. Celle a, b, , F. Beaufils a, b, M. Campagnac a, b, O. Ousova a, b, G. Cardouat a, b, J.-W. Dupuy a, b, T. Leste-Lasserre a, b, R. Marthan a, b, c, P.-O. Girodet a, b, c, P. Berger a, b, c, T. Trian a, b, P. Esteves a, b
a Univ-Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux, Ua Département de Pharmacologie, CIC, Bordeaux, France 
b Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux U, Plateforme Transcriptome NeuroCentre Magendie, U Functionnal Genomics Center (CGFB), Proteomics Facility, CIC, Bordeaux, France 
c CHU de Bordeaux, Service d’Exploration Fonctionnelle Respiratoire, Service de pharmacologie, CIC Service de chirurgie Thoracique, Pessac, France 

Corresponding author.

Resumen

Introduction

Asthma represents the most frequent chronic inflammatory condition among children. Infections of the bronchial epithelium (BE) by viruses are the primary cause of exacerbations with rhinoviruses (RV) detected in 85% of cases, especially RV-C, responsible for 67.5% of paediatric cases. The RV-C uses cadherin-related family member 3 (CDHR3) as a unique receptor, enabling its entry and then an efficient replication. CDHR3 variants, notably the rs6967330 A allele increases CDHR3 expression, increasing RV-C infection in nasal airway epithelial cells from childhood asthma cohort [1] . They also showed that CDHR3 knockout reduces transepithelial resistance, suggesting that its expression influences epithelial barrier integrity. This variant is linked to higher asthma exacerbation rates and greater RV-C infection risk in children hospitalized for respiratory infections [2] . We hypothesize that CDHR3 is overexpressed in asthmatic vs non-asthmatic paediatric BE, promoting viral entry and replication, weakening more the barrier, and aggravate asthma exacerbations.

Methods

Cell culture: BE cells from bronchial brushing of children were seeded (100,000 cells) on ALI transwells (0.4 μm pores, Corning Costar) with ALI medium (StemCell) at the basal pole.

RV infection: BE were infected with RV-C at MOI 0.1. After 1 h, the mix was removed, and experiments performed 24 h later.

Immunofluorescence: BE cells were fixed (4% PFA), permeabilized (Triton X-100), blocked (4% BSA), and incubated overnight at 4 °C with primary antibodies (1: 500), followed by Alexa Fluor™ 488/568 secondary antibodies. Membranes were excised, mounted (Fluoromount™), and imaged using an SPE1 confocal microscope. Image analysis was done with ImageJ and Imaris.

Western blotting: total proteins from bronchial epithelial cells were extracted, quantified, and analyzed by Western blot to detect CDHR3, ZO-1, and Claudin-1, with normalization to total protein levels.

TEER: TEER was measured using a specialized voltmeter (Evom 3 , World Precision Instruments) in bronchial epithelial cells from non-asthmatic and asthmatic patients at baseline and every 24 h for 5 days following RV-C infection.

Results

Under basal conditions, BE composition did not differ between healthy and asthmatic children. However, paediatric asthmatic BE showed increased CDHR3 expression. Moreover, BE impermeability was reduced. The increased CDHR3 expression could promote higher susceptibility to viral infection, which, may further exacerbate the impairment of epithelial barrier function observed in infected asthmatic BE.

Conclusion

Higher CDHR3 expression in asthmatic BE may compromise barrier integrity by facilitating RV-C infection and worsening asthma exacerbations.

El texto completo de este artículo está disponible en PDF.

Keywords : Asthma, Bronchial Epithelium


Esquema


© 2025  Publicado por Elsevier Masson SAS.
Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 43 - N° 1

P. 15 - mai 2026 Regresar al número
Artículo precedente Artículo precedente
  • Implication des macrophages interstitiels dans la réparation épithéliale au cours de la BPCO
  • L. Hurault, M. Nadaud, O. Cazorla, A. Petit, I. Vachier, A. Bourdin, Q. Bai
| Artículo siguiente Artículo siguiente
  • Intranasal BCG immunization protects against Streptococcus pneumoniae through the alteration of macrophage activity
  • J. Fine, C. Costa, L. Van Maele, C. Rouanet, J.-C. Sirard, A. Machelart

¿Ya suscrito a @@106933@@ revista ?